Symphytum ibericum Steven: LC–HRMS/MS-based phytochemical profile, in vitro antioxidant and enzyme inhibitory potential
Chemical and Biological Technologies in Agriculture volume 9, Article number: 42 (2022)
Symphytum L. (comfrey, Boraginaceae) has a longstanding use as a remedy to alleviate the clinical symptomatology in arthritis, strains, contusions or sprains. In the recent years, considerable research efforts were put into assessing the chemico-biological profile of unexploited Symphytum species, with the aim to extend the medicinal valences of the genus to new pharmacological applications. However, to date there are no previous comprehensive phytochemical characterization and multi-biological evaluation of S. ibericum Steven, a perennial Boraginaceae plant distributed in the Northeastern Turkey and Caucasus region.
Total phenolic and flavonoid content of extracts obtained from the leaves and roots of S. ibericum varied between 10.53 ± 0.20 to 84.95 ± 0.60 mg gallic acid equivalents/g and between 0.81 ± 0.06 to 20.88 ± 0.29 mg rutin equivalents/g. The liquid chromatography hyphenated with tandem high-resolution mass spectrometry (LC–HRMS/MS)-based phytochemical profiling revealed a number of 29 distinct compounds, such as phenolic acids (e.g., caffeic acid, rosmarinic acid, globoidnan B, rabdosiin, globoidnan A), flavonoids (e.g., quercetin derivatives, luteolin, apigenin), pyrrolizidine alkaloids (e.g., intermedine–N-oxide, lycopsamine-N-oxide, symphytine-N-oxide), organic and oxygenated unsaturated fatty acids. The evaluation of the antioxidant activity showed potent scavenging activity against synthetic radicals, cupric ion reducing (37.60 ± 0.15–436.26 ± 7.12 mg Trolox equivalents/g), ferric ion reducing (21.01 ± 0.74–229.99 ± 3.86 mg Trolox equivalents/g) and chelating capacity; in general, the leaf extracts displayed superior antioxidant effects than the corresponding root extracts. With respect to the inhibitory activity tested on various pharmacologically relevant enzymes, interesting anti-acetylcholinesterase (0.32 ± 0.03–3.32 ± 0.12 mg galanthamine equivalents/g), anti-butyrylcholinesterase (0.88 ± 0.06–5.85 ± 0.16 mg galanthamine equivalents/g) and anti-tyrosinase (21.84 ± 0.21–61.94 ± 2.86 mg kojic acid equivalents/g) properties were noticed. Exploratory multivariate analysis revealed four clusters with respect to phytochemical profile, of which one rich in danshensu, quercetin hexoside, dehydrorabdosiin, dihydrogloboidnan B and quercetin acetylhexoside.
As evidenced through the phytochemical characterization and multi-biological evaluation, S. ibericum can be regarded as a prospective source of pharmaceutical or cosmeceutical ingredients with putative uses in the management of chronic conditions linked to oxidative stress, such as Alzheimer’s disease or skin pigmentation disorders.
Symphytum officinale L. (comfrey) is one of the most well-known and studied species of the Boraginaceae, a family that comprises around 130 genera and 2300 species distributed around the world, in both tropical and temperate regions [1, 2]. Ethnopharmacologically, different internal (tinctures, infusions, decocts) or external (compresses, ointments) formulations prepared from the roots (Symphyti radix), leaves (Symphyti folium) or whole aerial parts (Symphyti herba) have been empirically used since Ancient times in swellings, bruises, phlebitis, contusions, respiratory, gastro-intestinal and genitourinary disorders [3,4,5,6]. Currently, comfrey-based topical applications are administered in the clinical symptomatology (inflammation, pain and swelling of joints and muscles) from arthritis, strains, contusions or sprains [7, 8]. These indications are based on the solid scientific knowledge acquired from numerous cell-free, cell-based, animal and human studies that demonstrated the efficacy (wound healing, antimicrobial, anti-inflammatory and anti-nociception potential), safety and tolerability profile of S. officinale preparations [4, 5, 9,10,11,12,13,14,15,16]. Comfrey contains four major classes of constituents: polysaccharides (up to 30% mucilage), purine derivatives (0.6–4.7% allantoin), polyphenols and pyrrolizidine alkaloids (PAs). Polysaccharides are considered one of the most potent biomolecules in comfrey, endowed with antioxidant, immunomodulatory, anticancer, hypoglycemic and hypolipidemic effects . Purine derivatives are degradation products of purine bases and nucleotides; in particular, allantoin was shown to exert wound healing (fibroblastic proliferation, extracellular matrix synthesis) and immunomodulatory activities . Polyphenols (e.g., rosmarinic acid, caffeic acid, chlorogenic acid, lithospermic acid, globoidnan A, globoidnan B, rabdosiin, etc.) are the most diverse and well-represented class of comfrey phytochemicals [6, 8, 19]. Rosmarinic acid is known for its numerous biological properties proven in different experimental models, such as anti-inflammatory, antioxidant, anticancer, antimicrobial and anti-allergic activities [4, 6]. Finally, comfrey PAs are a large group of 1,2-unsaturated necine ring structures (usually retronecine-type) that can occur either as free bases or as their N-oxides (PANOs). The most common PAs in S. officinale as well as other Symphytum species are intermedine, lycopsamine, 7-acetylintermedine, 7-acetyllycopsamine, echimidine, symphytine and their corresponding PANOs . However, since PAs are linked with serious health problems, particularly hepato-, cyto-, pneumo- and geno-toxicity, the use of comfrey-based preparations is partly overshadowed. In addition, the European Medicines Agency  restricted the intake of PAs-containing or PAs-contaminated herbal medicinal products to a maximum limit of 1 μg PAs/day.
Nevertheless, in the recent years, considerable research efforts were put into assessing the chemico-biological profile of several other unexploited Symphytum species. For instance, Zengin et al. . showed that S. aintabicum Hub.-Mor. & Wickens, is a rich source of bioactive constituents, such as phenolic acids (vanillic, gallic, ferulic, cinnamic, coumaric, caffeic, syringic, chlorogenic acids), flavonoids (kaempferol-3-O-glucoside, quercetin, hyperoside, quercitrin) and secoiridoids (swertiamarin, sweroside). In addition, various methanolic and aqueous aerial part extracts of S. aintabicum displayed significant antioxidant activity and acted as cholinesterase and tyrosinase inhibitors . Similarly, the ethyl acetate, methanol and aqueous aerial part extracts of S. anatolicum Boiss. exhibited potent antioxidant properties as well as anti-tyrosinase, anti-amylase and anti-cholinesterase effects, which could be attributed to their complex phytochemical profile, mostly phenolic acids (caffeic, chlorogenic, ferulic, gallic, and rosmarinic acids, salvianolic acids A and C, rabdosiin) and flavonoids (hyperoside, luteolin, quercetin, hesperidin, rutin, isoquercitrin) [2, 22]. Beside the chemosystematics importance, the above-mentioned studies also revealed the potential use of these species as rich sources of pharmaceutical or cosmeceutical ingredients in the management of chronic conditions linked to oxidative stress, such as diabetes, Alzheimer’s disease or skin pigmentation disorders. It is, therefore, imperious to thoroughly bio-prospect other poorly studied Symphytum species that can be subsequently exploited at industrial, agricultural or pharma-technological scale.
Symphytum ibericum Steven (creeping comfrey, dwarf comfrey, Iberian comfrey) is a perennial Boraginaceae plant distributed in the Northeastern Turkey and Caucasus region. The stems can grow up to only 27–38 cm, with ovate to ovate-lanceolate leaves; the basal leaves are petiolate, whereas the cauline leaves are shortly petiolate; the inflorescences are grouped into cymes, with a hairy calyx of 4–5 mm and a cream corolla . Except for a few botanical (anatomical, morphological) and taxonomical studies [23,24,25,26], there are no further investigations on this particular species. Therefore, the aim of our study was to perform a comprehensive liquid chromatography hyphenated with tandem high-resolution mass spectrometry (LC–HRMS/MS) phytochemical profiling of S. ibericum leaf and root extracts obtained with solvents with different polarity. In addition, the antioxidant (free radical scavenging, reducing power and chelating) and enzyme inhibitory effects (cholinesterase, tyrosinase, amylase, and glucosidase) were evaluated by in vitro assays. Finally, the chemico-biological differences within the leaf and root extracts of S. ibericum were explored via clustered image map (CIM) analysis, principal component analysis (PCA), hierarchical cluster analysis (HCA) and correlation (Corr) analysis.
Plant material and extraction
The leaves and roots of Symphytum ibericum Steven were collected in August 2021 from material cultivated at the Botanical Garden München–Nymphenburg (Munich, Germany, IPEN no. GE-0-M-2012/2393, 48° 09′ 50″ N, 11° 30′ 02″ E and 531 m). The region has a mild climate characterized by annual precipitation of 1000 mm and an average temperature of 8.8 °C. The cultivated plant stems originate from a wild population from Imereti Province in Georgia, between Tskaltubo and Tsageri (42° 34′ 25″ N, 42° 40′ 07″ E and 563 m) (A. Gröger et al. 226–4, 30-VIII-2012).
After drying, 5 g of ground plant material (leaves, roots) were separately extracted with 50 mL of chloroform, acetone, ethanol (25–100%) and water in an ultrasound bath, at room temperature for 30 min. After filtration, fresh solvent was added and the extraction procedure was repeated two more times. The pooled filtrates were evaporated to dryness, yielding leaf extracts of chloroform (LC, 0.18 g), acetone (LA, 0.06 g), ethanol (LE100, 0.11 g), 75% ethanol (LE75, 0.52 g), 50% ethanol (LE50, 0.35 g), 25% (LE25, 0.31 g) and water (LW, 0.57 g) extracts as well as root extracts of chloroform (RC, 0.08 g), acetone (RA, 0.03 g), ethanol (RE100, 0.09 g), 75% ethanol (RE75, 0.48 g), 50% ethanol (RE50, 0.59 g), 25% (RE25, 0.51 g) and water (RW, 0.54 g).
Total phenolic content (TPC), and total flavonoid content (TFC) were assessed spectrophotometrically as described in [27, 28], with data expressed as mg gallic acid equivalents (GAE)/g extract, and rutin equivalents (RE)/g extract, respectively. LC–HRMS/MS analysis was performed on an Agilent 1200 HPLC system (Agilent Technologies, Palo Alto, CA, USA) equipped with a binary pump (G1312C), column thermostat (G1316A), auto-sampler (G1329B) and accurate–mass quadrupole–time-of-flight MS detector (G6530B). The chromatographic separations were performed under the following conditions: column Phenomenex Gemini C18 (2 × 100 mm, 3 μm); column temperature 20 °C; mobile phase 0.1% formic acid in water (A) and 0.1% formic acid in acetonitrile (B); gradient 5–60% B (0–45 min), 95% B (46–50 min); flow rate 0.2 mL/min; injection volume 2 μL. The following MS parameters were used: Agilent dual jet stream (AJS) electrospray ionization source (ESI); full-scan high-resolution accurate–mass acquisition mode; negative and positive mode; m/z range 100–1000; gas (N2) temperature 275 °C; N2 flow 10 L/min; nebulizer 35 psi; sheath gas temperature 325 °C; sheath gas flow rate 12 L/min; capillary voltage 4000 V; nozzle voltage 1000 V; skimmer 65 V; fragmentor 140 V; fixed collision-induced dissociation energies 10 and 30 V. Data acquisition was achieved with MassHunter Workstation Data Acquisition 8.0, whereas MassHunter Workstation Qualitative Navigator 8.0 was used for data analysis. Peak assignment from the base peak chromatograms (BPC) of the analyzed samples was carried out by comparing the spectro-chromatographic data with previous literature reporting the LC–MS analysis of similar constituents from Symphytum [1, 6, 13, 15, 20] or online databases (METLIN, KNApSacK, PubChem, NIST Chemistry WebBook).
Antioxidant and enzyme inhibitory assays
The antioxidant and enzyme inhibitory assays were performed according to methods previously described [27, 28]. 1,1-Diphenyl-2-picrylhydrazyl (DPPH) and 2,2-azino-bis(3-ethylbenzothiazoline) 6-sulfonic acid (ABTS) radical scavenging activity, cupric ion reducing antioxidant capacity (CUPRAC) and ferric ion reducing antioxidant power (FRAP) were expressed as mg Trolox equivalents (TE)/g extract. The metal chelating ability (MCA) was provided as mg EDTA equivalents (EDTAE)/g extract, whereas the total antioxidant activity (phosphomolybdenum assay, PBD) was given as mmol TE/g extract. Acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) inhibitory activities were expressed as mg galanthamine equivalents (GALAE)/g extract; tyrosinase inhibitory potential was provided as mg kojic acid equivalents (KAE)/g extract; amylase and glucosidase inhibitory effects were presented as mmol acarbose equivalents (ACAE)/g extract.
All the experiments were performed in triplicate, with the results given as mean ± standard deviation (SD). One-way analysis of variance with Tukey’s post-hoc test was conducted using XLSTAT software; p < 0.05 was considered statistically significant. The chemical data sets (base peak areas extracted from the LC–HRMS/MS profiling) were logarithmically transformed, scaled, centered and submitted to CIM analysis. The bioactivities data sets were also scaled, centered and subsequently submitted to the PCA and HCA. For both CIM and HCA, “Ward’s rule” and “Euclidean distance” were employed in sample clustering. The relationship between the phytochemical composition and investigated bioactivities was evaluated by Corr analysis; a Pearson’s coefficient above 0.7 was considered significant. CIM, PCA, HCA and Corr analysis were performed using R v 4.1.2 software.
Results and discussion
Total phenolic and flavonoid content
To assess the TPC and TFC of S. ibericum, the leaves and roots were separately extracted with solvents with different polarities (chloroform, acetone, ethanol 25–100% and water). With respect to the extraction solvents (Table 1), it can be noticed that ethanol 75% and water led to the highest yields among the leaf extracts, whereas ethanol 25–75% and water displayed considerable higher extract masses than the other root extracts.
Overall, the leaf extracts (23.28 ± 0.18–84.95 ± 0.60 mg GAE/g) showed higher TPC than the root extracts (10.53 0.20–28.70 ± 0.12 mg GAE/g) (Table 1). Furthermore, the medium polarity solvents (ethanol 25–100%) allowed the highest recovery of polyphenols from the leaves and roots of S. ibericum. This is in agreement with the conventional processing of comfrey, as European Medicines Agency lists in the “Assessment report on Symphytum officinale L., radix” only medicinal preparations obtained with ethanol, ethanol 65% or ethanol 60% . In addition, the TPC of S. ibericum is comparable with the TPC reported in other Symphytum species, such as S. officinale leaf and root extracts (5.39–125.50 mg GAE/g), S. aintabicum aerial part extracts (35.50–112.25 mg GAE/g) and S. anatolicum aerial part extracts (11.45–44.75 mg GAE/g) [1, 2, 7, 22].
From all the leaf extracts, TFC reached its peak in LE25 (6.19 ± 0.27 mg RE/g), with the remaining values ranging from 1.48 ± 0.12 mg RE/g (LW) to 4.72 mg RE/g (LE75). In general, the root extract contained lower TFC than the corresponding leaf extracts (0.81 ± 0.06–5.14 ± 0.10 mg/g), with the exception of RA (20.88 ± 0.29 mg RE/g) and RE100 (13.27 ± 0.16 mg RE/g) that showed unusually higher amounts of flavonoids (Table 1). Previous research reported TFC values ranging from 0.19 to 33.89 mg RE/g in S. officinale, 2.54 to 25.12 mg RE/g in S. aintabicum or 2.74 to 13.30 mg RE/g in S. anatolicum [1, 2, 7, 22].
LC–HRMS/MS phytochemical profiling
The spectro-chromatographic results (retention time, molecular formula, m/z of the molecular and fragment ions) of the LC–HRMS/MS profiling are provided in Table 2, while the base peak chromatograms are given in Additional file 1: Figures S1 and S2. A total number of 29 specialized metabolites belonging to different phytochemical classes (phenolic acids, flavonoids, fatty acids and PAs) were assigned in the leaf and root extracts of S. ibericum. Of these, the highest number of constituents (17–18) were found in LE50, LE100, LW and RE75, followed by 15 phytochemicals in RA, RE100, LA, LE50 and LE25, 13 in RE50, 10 in RW, nine in RC and RE25 and eight in LC.
Phenolic acids were the most abundant group, represented by danshensu (Si7), hydroxybenzoic acid (Si10) and its hexoside (Si6), caffeic acid (Si11), dihydrogloboidnan B (Si14), globoidnan B (Si15), rabdosiin (Si20), rosmarinic acid (Si21), dehydrorabdosiin (Si22) and globoidnan A (Si23). Rosmarinic acid is a ubiquitous constituent of Symphytum genus, while rabdosiin, globoidnans A and B were only recently isolated from S. officinale [4, 15] and proposed as phytochemical markers in comfrey roots obtained from the spontaneous European flora or experimental and commercial crops [3, 20]. The fragmentation patterns of the rather unusual derivatives, such as dihydrogloboidnan B (Si14) and dehydrorabdosiin (Si22), are proposed in Additional file 1: Figure S3. Overall, the LC–HRMS/MS fingerprinting of the phenolic acid profile of S. ibericum revealed a significant overlapping with S. officinale [1, 4, 6, 13, 15, 20] and in a lesser extent with S. aintabicum  and S. anatolicum [2, 22].
As a member of the Boraginaceae family, S. ibericum contained several PAs, putatively labeled as dihydroechinatine (Si3), intermedine-N-oxide (Si4), lycopsamine-N-oxide (Si5), 7-sarracinyl-9-trachelantylretronecine-N-oxide (Si10), symphytine-N-oxide (Si12), 7-hydroxmethylbutyryl-9-trachelanthylretronecine (Si13) and 3'-acetylsymphytine-N-oxide (Si16). Compounds Si4, Si5, Si10, Si12 and Si16 (or their stereoisomers) were repeatedly reported in S. officinale [1, 3]. Furthermore, the presence of echimidine, lycopsamine and symphytine was previously shown by thin layer chromatographic analyses in S. ibericum . Nevertheless, since dihydroechinatine, 7-sarracinyl-9-trachelantylretronecine-N-oxide, 7-hydroxymethylbutyryl-9-trachelanthylretronecine and 3'-acetylsymphytine-N-oxide have unusual structures, their HRMS/MS fragmentation patterns were proposed in Additional file 1: Figure S4.
A number of six flavonoids were tentatively annotated in S. ibericum, namely, hexoside (Si17), rhamnoside (Si18) and acetylhexoside (Si19) of quercetin as well as the aglycons luteolin (Si24), cirsimaritin (Si27) and apigenin (Si28). Interestingly, all these phytochemicals were found only in the leaf extracts, suggesting that the underground parts do not accumulate/biosynthesize flavonoids. A similar trend was noticed for S. officinale and Anchusa ochroleuca M. Bieb., another member of the Boraginaceae family . Quercetin hexoside (such as hyperoside, quercetrin, or isoquercitrin), quercetin acetylhexoside and luteolin were previously reported in S. officinale, S. aintabicum or S. anatolicum [2, 7, 22].
Finally, three organic acids, such as malic (1), citric (2) and trachelantic/viridifloric acids (8) as well as three oxygenated unsaturated fatty acids, such as trihydroxyoctadecadienoic acid isomers (25, 26) and trihydroxyoctadecenoic acid (29), were assigned as non-specific metabolites in the leaf and root extracts of S. ibericum. As expected, the hydrophilic organic acids were mostly distributed in the polar extracts (RE25–75, RW, LE75–L25, LW), whereas the hydrophobic fatty acids were majorly found in the non-polar extracts (RC, RA, RE, LC, LA, LE). The occurrence of organic and fatty acids in Symphytum genus has been recently brought into attention through different LC–MS analyses [1, 20, 29].
The antioxidant potential of the 14 extracts of S. ibericum (roots and aerial parts) was investigated through a series of complementary assays, such as radical scavenging, reducing and chelating tests (Table 3). The radical scavenging activity varied between 13.37 ± 0.26 mg TE/g (LC) and 184.19 ± 0.19 mg TE/g (LE50) in the DPPH assay and between 5.95 ± 0.61 mg TE/g (RC) and 293.97 mg TE/g (LE50) in the ABTS assay. RE75 showed the most significant radical scavenging effects (48.24 ± 0.04 mg TE/g in DPPH assay and 90.99 ± 0.63 mg TE/g in ABTS assay) in the roots; nevertheless, the activity of the root extracts was inferior to that displayed by the corresponding leaf extracts. Previously, various extracts of S. officinale (roots and aerial parts) showed comparable DPPH and ABTS radical scavenging effects (7.94–189.87 mg TE/g in DPPH assay and 0.51–257.57 mg TE/g in ABTS assay) . Similarly, the aerial part extracts of S. anatolicum exhibited 24.57–95.76 mg TE/g in DPPH test and 53.95–197.00 mg/g in ABTS test [2, 22], whereas the aerial part extracts of S. aintabicum displayed values of 0.56–232.34 mg TE/g (DPPH) and 109.98–389.96 mg TE/g (ABTS) . When assessing the reducing power of the 14 extracts of S. ibericum, a very strong potency was noticed in LE50 (436.26 ± 7.12 mg TE/g in CUPRAC and 229.99 ± 3.86 mg TE/g FRAP), whereas the root extracts were significantly less active than the corresponding leaf extracts (Table 3). Our values are comparable with those reported in the aerial part and root extracts of S. officinale (15.78–553.32 mg TE/g in CUPRAC and 6.74–299.86 mg TE/g in FRAP), aerial part extracts of S. anatolicum (95.92–217.52 mg TE/g in CUPRAC and 68.22–162.22 mg TE/g in FRAP) and aerial part extracts of S. aintabicum (106.20–575.69 mg TE/g in CUPRAC and 47.89–379.90 mg TE/g in FRAP) [1, 2, 7, 22].
The MCA revealed that LE50 (22.54 ± 0.13 mg EDTAE/g), LE25 (22.24 ± 0.16 mg EDTAE/g) and RC (22.65 ± 1.61 mg EDTAE/g) were the most potent extracts. Thus, the MCA of S. ibericum is similar with the MCA of the aerial part and root extracts of S. officinale (1.09–32.25 mg EDTAE/g) and aerial part extracts of S. anatolicum (2.98–24.12 mg EDTAE/g) and S. aintabicum (6.77–17.99 mg EDTAE/g) [1, 2, 7, 22]. Finally, with respect to the PBD assay, the activity of all samples varied from 0.60 ± 0.02 mmol TE/g (LW) to 2.69 ± 0.04 mmol TE/g (LE100). Similar decreasing activity orders were noticed for the leaf (LE100 > LA > LE25 > LE75 > LE50 > LC > LW) and root extracts (RE100 > RA > RC > R75 > R25 > R50 > RW). The total antioxidant activity of different extracts of S. officinale (0.30–2.68 mmol TE/g), S. anatolicum (1.02–2.98 mmol TE/g) and S. aintabicum (0.82–2.79 mmol TE/g) was comparable to our data [1, 2, 7, 22].
Enzyme inhibitory activity
In this section, the inhibitory activity of the root and aerial part extracts of S. ibericum against several key enzymes involved in the management of Alzheimer’s disease (AChE, BChE), skin disorders (tyrosinase) and type 2 diabetes mellitus (amylase, glucosidase) was evaluated (Table 4). In general, all extracts acted as cholinesterase inhibitors, except for the LW and RW; the anti-AChE activity values ranged between 0.32 ± 0.03–2.77 ± 0.09 mg GALAE/g in the root samples and 1.43 ± 0.05–3.32 ± 0.12 mg GALAE/g in the leaf samples. Nevertheless, a significantly higher BChE inhibitory potential was noticed in the leaf and root extracts, with the maximum activity achieved in RE100 (7.51 ± 0.42 mg GALAE/g) followed by LE100 (5.85 ± 0.16 mg GALAE/g). Our data is in agreement with the anti-cholinesterase properties reported previously for extracts of S. officinale (1.79–2.40 and 1.23–2.35 mg GALAE/g in AChE and BChE assays, respectively), S. aintabicum (2.50–2.68 and 4.32–6.04 mg GALAE/g in AChE and BChE assays, respectively) or S. anatolicum (2.24 and 1.44 mg GALAE/g in AChE and BChE assays, respectively) [1, 2, 7].
The anti-tyrosinase effects of S. ibericum reached the highest peaks in RE100 (61.94 ± 2.86 mg KAE/g) and LE100 (51.05 ± 3.96 mg KAE/g), whereas the activity of the remaining samples varied from 21.84 ± 0.21 mg KAE/g (RE50) and 45.26 ± 0.48 mg KAE/g (RC); three extracts (LW, RE25 and RW) were inactive (Table 4). The previous literature data also revealed significant anti-tyrosinase effects of the extracts obtained from S. officinale (18.15–43.89 mg KAE/g), S. aintabicum (9.52–13.72 mg KAE/g) or S. anatolicum (58.40–98.60 mg KAE/g) [1, 7, 22]. A considerable number of extracts (LC, LA, LE100, LE25, RC, RA, RE100) displayed an amylase inhibitory activity higher than 0.40 mmol ACAE/g, whereas the anti-glucosidase potential was slightly better, with four samples (LE50, LW, RE25 and RW) showing a value of 0.97 ± 0.00 mmol ACAE/g. As compared to the extracts of S. officinale (0.24–0.79 and 6.86–11.62 mmol ACAE/g in amylase and glucosidase assays, respectively), S. anatolicum (0.13–0.61 and 2.36 mmol ACAE/g in amylase and glucosidase assays, respectively) or S. aintabicum (0.41–0.65 mmol ACAE/g in amylase assay), S. ibericum exhibited slightly lower anti-amylase and anti-glucosidase properties [1, 2, 7, 22].
Exploratory multivariate analysis
To further explore the chemico-biological variability and interactions of the S. ibericum leaf and root extracts, multivariate analysis was performed, including CIM, PCA, HCA and Corr. By examining the resulting heatmap from the CIM analysis of the phytochemical composition, four clusters were retained (Fig. 1). Overall, the samples of cluster A (LE50, LE25, LW and LE75) were substantially rich in danshensu (Si7), quercetin hexoside (Si17), dehydrorabdosiin (Si22), dihydrogloboidnan B (Si14) and quercetin acetylhexoside (Si19), while the samples of cluster B (LE100 and LA) were significantly rich in apigenin (Si28), luteolin (Si24) and quercetin rhamnoside (Si18).
PCA of the antioxidant and anti-enzymatic activities was subsequently performed; the scree plot of the eigenvalues and percentages of the explained variances were explored to select the smallest number of dimensions synthesizing most of the variation in data. Based on Kaiser’ criterion , the first three dimensions, manifesting a variance of 36.5%, 34.2% and 14.5%, respectively, were kept (Fig. 2A). Next, the barplots were graphed to investigate the contribution of the bioactivities on the three retained dimensions. As observed in Fig. 2B, the first dimension was predominantly linked to three bioactivities (DPPH, ABTS and FRAP), the second dimension was significantly bound to four (PBD, AChE, tyrosinase and CUPRAC), while the third dimension was essentially linked to two bioactivities (glucosidase and MCA). The scatter plots (Dim1 vs. Dim2, Dim1 vs. Dim3 and Dim2 vs. Dim3) were then examined to determine the different clusters. Despite the considerable variability that can be observed among the samples, it was not possible to identify accurately different clusters (Fig. 2C). To that end, only HCA allowed to obtain a clearer picture of the clusters (Fig. 3). As observed in the dendogram (Fig. 3), S. ibericum samples could be split into four major clusters. Remarkably, LE50 stood out from the other samples, which might be related to its highest radical scavenging and reducing power activities.
Finally, to explore the relationship between the phytochemical profile of S. ibericum and investigated bioactivities, Corr analysis was performed. Based on the calculated Pearson’s coefficients (Fig. 4), it was first noticed that the radical scavenging and reducing power activities were positively linked to the TPC. Second, several individual constituents seemed to contribute to different bioactivities; for instance, danshensu (Si7), dihydrogloboidnan B (Si14), quercetin hexoside (Si17), quercetin acetylhexoside (Si19), dehydrorabdosiin (Si22), cirsimaritin (Si27) were positively correlated with both FRAP and CUPRAC, while quercetin acetylhexoside (Si19) and dehydrorabdosiin (Si22) might be significantly involved to the ABTS radical scavenging activity. With respect to the anti-enzymatic activity, no important correlations were noticed. In essence, the different bioactivities exhibited by the extracts of S. ibericum can be attributed to the synergetic or additive action of multiple compounds, as previously noticed by other groups .
To the best of our knowledge, this is the first study to report the phytochemical composition and multi-biological potential of S. ibericum. The LC–HRMS/MS-based profiling of the 14 extracts obtained with solvents with different polarity from the roots and leaves evidenced a complex metabolite composition, with numerous phenolic acids, flavonoids, PAs, organic and oxygenated unsaturated fatty acids. Overall, the antioxidant activity, as evaluated through radical scavenging (DPPH, ABTS), reducing (CUPRAC, FRAP) and chelating assays, revealed a higher efficacy of the leaf extracts than the corresponding root extracts as well as more potent effects of the polar extracts than the non-polar extracts. With respect to the inhibitory activity against several key enzymes involved in the management of Alzheimer’s disease, skin disorders and type 2 diabetes mellitus, good anti-AChE, anti-BChE and anti-tyrosinase effects were observed for some extracts of S. ibericum. Exploratory multivariate analysis (CIM, PCA, HCA, Corr) revealed four clusters with respect to the phytochemical profile, with one cluster rich in danshensu, quercetin hexoside, dehydrorabdosiin, dihydrogloboidnan B and quercetin acetylhexoside and four clusters with respect to the biological activities, among which sample LE50 represented an individual group. Aside from the chemosystematics importance, our study could represent a starting point toward the subsequent large-scale exploitation of this previously uninvestigated Symphytum species as agricultural commodity or bio-functional ingredient for nutraceutical, pharmaceutical or cosmeceutical industries. Furthermore, to overcome the well-known toxicological issues raised by the presence of the PAs, implementing technologies that allow obtaining PAs-depleted extracts or using active formulas that contain purified fractions could be explored. Finally, further preclinical and clinical studies are imperious to confirm whether S. ibericum can be indeed included in the management of chronic conditions linked to oxidative stress, such as Alzheimer’s disease or skin pigmentation disorders.
Availability of data and materials
The data sets used and/or analyzed during the current study are available from the corresponding author on reasonable request.
Trifan A, Zengin G, Sinan KI, Wolfram E, Skalicka-Woźniak K, Luca SV. LC-HRMS/MS phytochemical profiling of Symphytum officinale L. and Anchusa ochroleuca M. Bieb. (Boraginaceae): Unveiling their multi-biological potential via an integrated approach. J Pharm Biomed Anal. 2021;204:114283.
Varvouni E-F, Zengin G, Graikou K, Ganos C, Mroczek T, Chinou I. Phytochemical analysis and biological evaluation of the aerial parts from Symphytum anatolicum Boiss. and Cynoglottis barrelieri (All.) Vural & Kit Tan (Boraginaceae). Biochem System Ecol. 2020;92:104128.
Trifan A, Zengin G, Sinan KI, Esslinger N, Grubelnik A, Wolfram E, et al. Influence of the post-harvest storage time on the multi-biological potential, phenolic and pyrrolizidine alkaloid content of comfrey (Symphytum officinale L.) roots collected from different European regions. Plants. 2021;10(9):1825.
Trifan A, Skalicka-Woźniak K, Granica S, Czerwińska ME, Kruk A, Marcourt L, et al. Symphytum officinale L.: Liquid-liquid chromatography isolation of caffeic acid oligomers and evaluation of their influence on pro-inflammatory cytokine release in LPS-stimulated neutrophils. J Ethnopharmacol. 2020;262:113169.
Salehi B, Sharopov F, Tumer TB, Ozleyen A, Rodríguez-Pérez C, Ezzat MS, et al. Symphytum species: a comprehensive review on chemical composition, food applications and phytopharmacology. Molecules. 2019;24(12):2272.
Trifan A, Opitz SE, Josuran R, Grubelnik A, Esslinger N, Peter S, et al. Is comfrey root more than toxic pyrrolizidine alkaloids? Salvianolic acids among antioxidant polyphenols in comfrey (Symphytum officinale L.) roots. Food Chem Toxicol. 2018;112:178–87.
Zengin G, Sinan KI, Ak G, Angeloni S, Maggi F, Caprioli G, et al. Preliminary investigation on chemical composition and bioactivity of differently obtained extracts from Symphytum aintabicum Hub.-Mor. & Wickens. Biochem System Ecolol. 2021;94:104203.
Staiger C. Comfrey: a clinical overview. Phytother Res. 2012;26(10):1441–8.
Kučera M, Barna M, Horáček O, Kováriková J, Kučera A. Efficacy and safety of topically applied Symphytum herb extract cream in the treatment of ankle distortion: results of a randomized controlled clinical double-blind study. Wien Medizin Wochenschr. 2004;154(21):498–507.
Barna M, Kucera A, Hladikova M, Kucera M. Randomized double-blind study: wound-healing effects of a Symphytum herb extract cream (Symphytum × uplandicum Nyman) in children. Arzneimittelforschung. 2012;62(06):285–9.
Barna M, Kucera A, Hladicova M, Kucera M. Wound healing effects of a Symphytum herb extract cream (Symphytum × uplandicum NYMAN:): results of a randomized, controlled double-blind study. Wien Medizin Wochenschr. 2007;157(21–22):569–74.
Kucera M, Barna M, Horácek O, Kálal J, Kucera A, Hladíkova M. Topical Symphytum herb concentrate cream against myalgia: a randomized controlled double-blind clinical study. Adv Ther. 2005;22(6):681–92.
Seigner J, Junker-Samek M, Plaza A, D‘Urso G, Masullo M, Piacente S, et al. A Symphytum officinale root extract exerts anti-inflammatory properties by affecting two distinct steps of NF-κB signaling. Front Pharmacol. 2019;10:289.
Vostinaru O, Conea S, Mogosan C, Toma C, Borza C, Vlase L. Anti-inflammatory and antinociceptive effect of Symphytum officinale root. Rom Biotechnol Lett. 2018;23:14160–7.
D’Urso G, Masullo M, Seigner J, Holper-Schichl YM, de Martin R, Plaza A, et al. LC–ESI–FT–MSn metabolite profiling of Symphytum officinale L. roots leads to isolation of comfreyn A, an unusual arylnaphthalene lignan. Int J Mol Sci. 2020;21(13):4671.
Grube B, Grünwald J, Krug L, Staiger C. Efficacy of a comfrey root (Symphyti offic radix) extract ointment in the treatment of patients with painful osteoarthritis of the knee: results of a double-blind, randomised, bicenter, placebo-controlled trial. Phytomedicine. 2007;14(1):2–10.
Chen S, Shang H, Yang J, Li R, Wu H. Effects of different extraction techniques on physicochemical properties and activities of polysaccharides from comfrey (Symphytum officinale L.) root. Ind Crops Prod. 2018;121:18–25.
Ruzicka J, Berger-Büter K, Esslinger N, Novak J. Assessment of the diversity of comfrey (Symphytum officinale L. and S. × uplandicum Nyman). Gen Res Crop Evol. 2021;68(7):1–13.
Sowa I, Paduch R, Strzemski M, Zielińska S, Rydzik-Strzemska E, Sawicki J, et al. Proliferative and antioxidant activity of Symphytum officinale root extract. Nat Prod Res. 2018;32(5):605–9.
Trifan A, Wolfram E, Esslinger N, Grubelnik A, Skalicka-Woźniak K, Minceva M, et al. Globoidnan A, rabdosiin and globoidnan B as new phenolic markers in European-sourced comfrey (Symphytum officinale L.) root samples. Phytochem Anal. 2021;32(4):482–94.
EMA. European Medicines Agency. Assessment report on Symphytum officinale L., radix. 2015.
Sarikurkcu C, Ozer MS, Tlili N. LC–ESI–MS/MS characterization of phytochemical and enzyme inhibitory effects of different solvent extract of Symphytum anatolicum. Ind Crops Prod. 2019;140:111666.
Akcin OE, Baki H. Micromorphology and anatomy of three Symphytum (Boraginaceae) taxa from Turkey. Bangl J Bot. 2007;36(2):93–103.
Akçin ÖE, Baki H. Fruit coat patterns and morphological properties of seven species of Symphytum L. (Boraginaceae) from Turkey. Bangl J Bot. 2009;38(2):185–8.
Jaarsma T, Lohmanns E, Hendriks H, Gadella T, Malingré T. Chemo-and karyotaxonomic studies on some rhizomatous species of the genus Symphytum (Boraginaceae). Plant System Evol. 1990;169(1):31–9.
Hacıoğlu BT, Erik S. Phylogeny of Symphytum L. (Boraginaceae) with special emphasis on Turkish species. Afr J Biotechnol. 2011;10(69):15483–93.
Uysal S, Zengin G, Locatelli M, Bahadori MB, Mocan A, Bellagamba G, et al. Cytotoxic and enzyme inhibitory potential of two Potentilla species (P. speciosa L. and P. reptans Willd.) and their chemical composition. Front Pharmacol. 2017;8:290.
Grochowski DM, Uysal S, Aktumsek A, Granica S, Zengin G, Ceylan R, et al. In vitro enzyme inhibitory properties, antioxidant activities, and phytochemical profile of Potentilla thuringiaca. Phytochem Lett. 2017;20:365–72.
Nastić N, Borrás-Linares I, Lozano-Sánchez J, Švarc-Gajić J, Segura-Carretero A. Comparative assessment of phytochemical profiles of comfrey (Symphytum officinale L.) root extracts obtained by different extraction techniques. Molecules. 2020;25(4):837.
Kaiser HF. A note on Guttman’s lower bound for the number of common factors 1. Br J Stat Psychol. 1961;14(1):1–2.
Junio HA, Sy-Cordero AA, Ettefagh KA, Burns JT, Micko KT, Graf TN, et al. Synergy-directed fractionation of botanical medicines: a case study with goldenseal (Hydrastis canadensis). J Nat Prod. 2011;74(7):1621–9.
SVL would like to kindly acknowledge Prof. Dr. Gudrun Kadereit and Dr. Simon Pfanzelt (Botanical Garden München-Nymphenburg, Germany) for providing the plant material of Symphytum ibericum Steven.
Open access funding enabled and organized by Projekt DEAL.
Ethics approval and consent to participate
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
LC–HRMS/MS chromatograms (base peak chromatograms) of Symphytum ibericum LEAF extracts. Figure S2. LC–HRMS/MS chromatograms (base peak chromatograms) of Symphytum ibericum ROOT extracts. Figure S3. Fragmentation pathways proposed for rare phenolic acids Figure S4. Fragmentation pathways proposed for rare pyrrolizidine alkaloids
About this article
Cite this article
Trifan, A., Zengin, G., Sinan, K.I. et al. Symphytum ibericum Steven: LC–HRMS/MS-based phytochemical profile, in vitro antioxidant and enzyme inhibitory potential. Chem. Biol. Technol. Agric. 9, 42 (2022). https://doi.org/10.1186/s40538-022-00308-0